China Pioneer Pharma Holdings Limited (1345.HK)

HKD 2.34

(-0.43%)

Market Cap (In HKD)

2.88 Billion

Revenue (In HKD)

1.56 Billion

Net Income (In HKD)

145.71 Million

Avg. Volume

76.74 Thousand

Currency
HKD
Country
Healthcare
Open
-
Prev. Close
-
Day Range
-
Year Range
1.31-2.45
PE
-
EPS
-
Beta Value
0.447
ISIN
KYG2162L1068
CUSIP
G2162L106
CIK
-
Shares
-
Earnings Annoncement
-

Company Profile

Sector
Healthcare
Industry
Medical - Pharmaceuticals
CEO
Mr. Yuewen Yang
Employee Count
-
Website
https://www.pioneer-pharma.com
Ipo Date
2013-11-05
Details
China Pioneer Pharma Holdings Limited, an investment holding company, markets, promotes, and sells pharmaceutical products and medical devices primarily in the People's Republic of China. It has a portfolio of pharmaceutical products, such as ophthalmology, pain management, cardiovascular, immunology, gynecology, gastroenterology, and other therapeutic areas, as well as medical devices, including ophthalmology, orthopedics, odontology, and wound care products. The company sells its products to hospitals and medical institutions, and pharmacies. It also sells ancillary tools and leases accessories; and sells dental devices. In addition, the company engages in the sale of imported in-licensed prescription products. China Pioneer Pharma Holdings Limited was founded in 1996 and is headquartered in Shanghai, the People's Republic of China. China Pioneer Pharma Holdings Limited is a subsidiary of Pioneer Pharma (BVI) Co., Ltd.

More Stocks